Published by the American Heart Association
As physicians, scientists, and researchers worldwide struggle to understand the novel coronavirus (COVID-19) pandemic, the American Heart Association (AHA) has developed a COVID-19 CVD Registry to aggregate data and aid research on the disease. The AHA hopes to gain insight into the clinical treatment patterns and variations, including the collection of biomarkers, as well as risk factors and cardiovascular outcomes in hospitalized COVID-19 patients across the nation.
"Having sufficient data is the first step to understanding the impact of COVID-19 on cardiovascular health," said John Warner, M.D., FAHA, chair of the quality oversight committee and past volunteer president of the American Heart Association and executive vice president for Health System Affairs at the University of Texas Southwestern Health System in Dallas, Texas. “As a trusted resource for data and research, with an entry point in more than 2,400 U.S. hospitals, the American Heart Association is uniquely positioned to gather data quickly and accurately.”
The AHA’s COVID-19 CVD Registry, powered by Get With The Guidelines® (GWTG), builds on 20 years of successful hospital quality improvement efforts. The no-cost registry will help inform the larger medical community and the aggregated, de-identified data set will be available to researchers through the Association’s Institute for Precision Cardiovascular Medicine in coming months.
In addition to being specifically designed to track all hospitalized adult COVID-19 patients to get real-time feedback from across the nation, the registry will include the following features:
- Access to national and regional benchmarks
- Ability to capture and customize site-specific data elements for patient population
- Ability to use key learnings and data for future pandemic preparedness
- Leverage the registry for powerful clinical insights and rapid research
- Enhanced measures and reports available in future iterations
Those interested in learning more, should download the fact sheet and visit the COVID-19 CVD Registry website for details on enrolling, benefits of participating, and more.